We are DermaScan.Skin-cancer screening,everywhere.Raising our Series A.
The thesis
Screening is becoming infrastructure, and infrastructure compounds.
Early detection already works. The bottleneck is access: screening is scarce, slow, and concentrated in a handful of cities, so most people never get it in time.
We turn screening into infrastructure: a standardized center that can open anywhere and be run by any health professional. High-quality detection within reach of everyone, not just those who live next to a specialist.
Every new center widens access and strengthens the network. That is how a screening company becomes category-defining: accessibility at scale, compounding with every site.
“Early detection saves lives. Access decides how many.”
The problem
Early detection works. The system around it doesn't.
1 in 5
people develop skin cancer in their lifetime
Incidence has tripled in 30 years, driven by UV exposure and an ageing population.
months
average wait for a dermatology appointment
Access is rationed by a shrinking number of specialists, and screening loses to urgent care.
~30%
5-year survival when melanoma is caught late
The same cancer caught early is ~99% survivable. The gap is detection timing.
The infrastructure
We built the infrastructure to solve the access problem.
Everything a high-quality screening center needs, engineered into four building blocks that reproduce anywhere.
Hardware
The proprietary LumaScan station: total-body mapping in one guided workflow.
Software
An in-house platform: video-dermoscopy app, patient pre-consultation portal, care coordination.
AI
An explainable safety net that supports the physician and never replaces them.
Training
A structured training program and a dedicated tech platform that bring any health professional up to the exact same protocol.
Live proof
We built it, deployed it, scaled it.
And we operated it ourselves in France: 6 centers live in 12 months, the fastest execution in the field. A model that scales easily, one turnkey center at a time.
6
centers live
5 opened in 2026, +4 by year-end
30%
contributive margin
up to, per mature center
10,800+
consultations
since Feb 2025
4.97/5
patient rating
600+ reviews
Designed, built and operated in-house. We know the unit economics because we run them.
Live in France
Why now
The proof is there. Time to deploy at scale and reach a €10B market.
Demand
Rising incidence and aging populations push demand up, while a shrinking dermatologist workforce pushes supply down. The specialist system can't absorb the gap, everywhere, not just in France.
Technology
Imaging hardware and AI have crossed the threshold where a standardized, high-quality center can be packaged and deployed by non-specialists.
Efficiency
The most pragmatic, rational answer to the need: trained GPs screen at scale, and specialists see only the cases that truly need them. Right care at the right level, no waste, no moonshot, a model that fits how care is actually delivered.
Team
Operators building the full stack in-house.
A talented core team of 7, plus 60+ partner health professionals across our centers.
Backed by Hexa (ex-eFounders), Ring Capital, Techmind, plus angels including Jean-Charles Samuelian, Céline Lazorthes and many physicians.
Join the round
Wanna be part of the movement?
The round
$6M
Take part in our Series A and help bring skin-cancer screening within everyone's reach.